# DeepSynaps Studio — Conversation Continuity Summary

**Date**: April 7, 2026  
**Status**: ALL 10 PHASES COMPLETE  
**User**: sehzadeyildirim@hotmail.com

---

## What Was Built

A complete clinical neuromodulation database (DeepSynaps Studio v2.0) integrating data from SOZO Brain Center's master protocol files, plus a full-stack web application for exploring the data.

### Database: 12 Tables, 332 Records

| Table | Records | Notes |
|---|---|---|
| Evidence_Levels | 4 | EV-A through EV-D |
| Governance_Rules | 12 | GOV-001 through GOV-012 |
| Modalities | 16 | 12 existing + tACS, PEMF, LIFU/tFUS, tRNS |
| Devices | 29 | Including Flow FL-100 (only PMA-approved tDCS) |
| Conditions | 31 | 20 existing + 11 new (deduplicated from 48 candidates) |
| Symptoms_Phenotypes | 6 | |
| Assessments | 22 | Full batteries per condition |
| Protocols | 100 | ALL status = "Pending" (never auto-published) |
| Sources | 37 | High-quality peer-reviewed papers |
| Brain_Regions (NEW) | 46 | FNON framework mapped |
| qEEG_Condition_Map (NEW) | 22 | Condition-to-qEEG biomarker links |
| qEEG_Biomarkers (NEW) | 7 | Core qEEG metrics |

### Evidence Distribution
- EV-A (Strong): 7 protocols
- EV-B (Moderate): 40 protocols
- EV-C (Emerging): 16 protocols
- EV-D (Preliminary): 37 protocols

### QA Results
- 53 tests passed, 0 failed, 0 warnings

---

## Non-Negotiable Constraints (Must Preserve)

These rules were established by the user and must never be violated:

1. **Regulatory status ≠ evidence strength** — always keep separate
2. **Never auto-publish** — every protocol enters review queue as "Pending"
3. **"FDA cleared" ≠ "FDA approved"** — precise terminology required
4. **Device listing/registration ≠ cleared intended use**
5. **Neurofeedback for ADHD = EV-D** unless new high-quality blinded evidence emerges
6. **Flow FL-100 = only PMA-approved tDCS device**
7. **Low confidence → mark "to verify"** — never guess
8. **No marketing language** in regulatory or evidence fields
9. **Ask before major schema changes**
10. **tACS, PEMF, LIFU, tRNS protocols → flag EV-C or EV-D + GOV-003**
11. **Off-label protocols → flag GOV-001**
12. **"FDA Breakthrough Designation" ≠ "FDA cleared"** — keep separate
13. **Full traceability and auditability** at all times

---

## Deliverables Created

### Data Files
- **Master Excel Workbook**: `/home/user/workspace/deepsynaps_output/DeepSynaps_Master_Database_v2.xlsx` (12 sheets)
- **CSV Exports**: `/home/user/workspace/deepsynaps_output/csv/` (12 CSV files, one per table)

### Documentation
- **Integration Report**: `/home/user/workspace/deepsynaps_output/Integration_Report.md`
- **Data Dictionary v2**: `/home/user/workspace/deepsynaps_output/Data_Dictionary_v2.md`
- **QA Report**: `/home/user/workspace/deepsynaps_output/QA_Report.md`

### Business
- **Pricing Strategy**: `/home/user/workspace/deepsynaps_pricing_strategy.md`
  - 4-tier model: Explorer (free), Clinician (€49/mo), Clinic Pro (€349/mo), Enterprise (custom)
  - Board context: €1.5M dev investment, €16.17M total 4-year spend
  - Target: 1M clinicians + 10M users

### Web Application
- **Location**: `/home/user/workspace/deepsynaps-app/`
- **Stack**: Express.js backend + React frontend + Tailwind CSS
- **Design**: Dark navy theme (#1F4E79 primary, #0D9488 accent)
- **Pages**: Dashboard, Data Explorer, Protocols, Brain Regions, qEEG Maps, Review Queue
- **Start command**: `cd /home/user/workspace/deepsynaps-app && npm start` (runs on port 5000)
- **Note**: Full-stack app — cannot be statically deployed, needs Express server

### Integration Script
- `/home/user/workspace/integration_phase2_7.py` — Main Python script that performed all data integration

---

## Source Files (User-Provided)

| File | Contents |
|---|---|
| `SOZO_Master_Neuromodulation_Protocols_v2.xlsx` | PRIMARY — 111 rows across 11 modality sheets (100 actual protocols; last row per sheet is "Source:" attribution) |
| `Master-with-QEEG-places.xlsx` | Conditions_QEEG_Map sheet |
| `Brain_Networks_qEEG_FNON.xlsx` | FNON framework, 46 brain regions, qEEG biomarkers (note: headers in row 2, data from row 3) |
| `Assessments_Master.xlsx` | 22 conditions × assessment batteries |
| `transcinal-pulse-stimulations-04-Apr-2026-1.csv` | 2,995 TPS/tFUS papers |
| `brain-networks-for-neurmodulation-04-Apr-2026.csv` | 86 papers |
| `brain-networks-04-Apr-2026.csv` | 95 papers |

---

## Key Technical Notes

1. **Protocol count is 100, not 111** — each of the 11 modality sheets has a final "Source:" attribution row that is not a protocol
2. **Brain_Regions FNON file** has a title row in row 1, headers in row 2, and data starting from row 3 — direct pandas read will misalign columns
3. **New conditions added (11)**: Schizophrenia (COND-021), Disorders of Consciousness (COND-022), MCI (COND-023), MS (COND-024), Fibromyalgia (COND-025), Cognitive Enhancement (COND-026), Inflammatory Arthritis (COND-027), Motor/Perceptual Learning (COND-028), Tourette's (COND-029), VCI (COND-030), MS-related Pain (COND-031)
4. **New modalities added (4)**: tACS (MOD-013), PEMF (MOD-014), LIFU/tFUS (MOD-015), tRNS (MOD-016)

---

## Session Flow

1. Read all 10 source files — mapped complete data inventory
2. Proposed 3 new tables (Brain_Regions, qEEG_Condition_Map, qEEG_Biomarkers) — user approved
3. User asked about pricing → created 4-tier pricing strategy with competitive analysis
4. User said "continue with this" → executed full integration (Phases 2–10)
5. First integration run hit error on FNON file (header offset) — fixed and re-ran
6. Generated all CSVs + Excel workbook
7. Built full-stack web app (Express + React + Tailwind)
8. QA: 53/53 passed
9. Generated all documentation (Integration Report, Data Dictionary, QA Report)
10. Started web app on port 5000 — confirmed 332 records served via API
11. Static deployment attempted but failed (app requires Express server)

---

## Organization Context

- **Company**: SOZO Brain Center (Cyprus)
- **CEO**: Matthew Papadopoulos
- **CTO**: Dr Ali Yildirim
- **Investment**: €1.5M development, €16.17M total 4-year projected spend
- **Market target**: 1M clinicians + 10M end users
